NDC 0781-3033-70 - Ampicillin and Sulbactam
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0781-3033
- Requested NDC
- 0781-3033-70
- Package NDCs from labels
- 0781-3033-70, 0781-3033-95
- Manufacturer
- Sandoz Inc
- Effective date
- 2020-10-29
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Ampicillin and Sulbactam - Sandoz Inc | Sandoz Inc | 2020-10-29 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0781-3033-70 | EA - Each | 0781-3033 | 074acb54-a714-47bc-a66f-0f9bac9c7e2f | 1 | 2012-07-24 |
| 0781-3033-95 | EA - Each | 0781-3033 | d2686d48-5f29-4200-bb21-d1fe75a4cd25 | 1 | 2013-02-13 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| AMPICILLIN SODIUM | ACTIVE INGREDIENT | JFN36L5S8K | AMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM AND SULBACTAM SODIUM) INJECTION, POWDER, FOR SOLUTION [SANDOZ INC] | 14 | |
| SULBACTAM SODIUM | ACTIVE INGREDIENT | DKQ4T82YE6 | AMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM AND SULBACTAM SODIUM) INJECTION, POWDER, FOR SOLUTION [SANDOZ INC] | 14 | |
| AMPICILLIN | ACTIVE MOIETY | 7C782967RD | AMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM AND SULBACTAM SODIUM) INJECTION, POWDER, FOR SOLUTION [SANDOZ INC] | 14 | |
| SULBACTAM | ACTIVE MOIETY | S4TF6I2330 | AMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM AND SULBACTAM SODIUM) INJECTION, POWDER, FOR SOLUTION [SANDOZ INC] | 14 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ampicillin | AMPICILLIN SODIUM | ProPharma Distribution | 364b1db9-e523-7bae-e063-6294a90a651d | 2025-07-18 | Warnings, Adverse reactions | JFN36L5S8K |
| Ampicillin sodium | AMPICILLIN | Civica, Inc. | 2fd0f9fa-5b86-42f7-9a9f-767123638d39 | 2025-06-30 | Warnings, Adverse reactions | JFN36L5S8K |
| Ampicillin | AMPICILLIN SODIUM | Sandoz Inc | 67dd2930-8482-4da5-b663-b751aff18c61 | 2025-05-16 | Warnings, Adverse reactions | JFN36L5S8K |
| Ampicillin | AMPICILLIN SODIUM | Sandoz Inc | 64a04e8c-8f78-46b3-8f45-56ef225a4f74 | 2025-02-21 | Warnings, Adverse reactions | JFN36L5S8K |
| Ampicillin | AMPICILLIN | Medical Purchasing Solutions, LLC | 29675d9c-3248-337a-e063-6294a90a2e20 | 2024-12-16 | Warnings, Adverse reactions | JFN36L5S8K |
| ampicillin and sulbactam | AMPICILLIN AND SULBACTAM | Sagent Pharmaceuticals | 35606b43-5914-423c-9bc7-fa3957eb2563 | 2024-11-18 | Warnings, Adverse reactions | JFN36L5S8K DKQ4T82YE6 |
| Ampicillin | AMPICILLIN SODIUM | Sandoz Inc | c2908a44-1da4-4885-ae5a-23f69189d91a | 2024-10-31 | Warnings, Adverse reactions | JFN36L5S8K |
| Ampicillin | AMPICILLIN SODIUM | Sandoz Inc | b371e1a5-1fef-4df2-8940-c4fc02b9e2f0 | 2024-10-31 | Warnings, Adverse reactions | JFN36L5S8K |
| Ampicillin | AMPICILLIN SODIUM | Sandoz Inc | 5308ddfa-4a5b-4f7b-83ce-9d1b528e050d | 2024-05-09 | Warnings, Adverse reactions | JFN36L5S8K |
| Ampicillin | AMPICILLIN SODIUM | Sandoz Inc | 6632a5bd-45f1-422f-80b0-46e5a628969a | 2024-05-08 | Warnings, Adverse reactions | JFN36L5S8K |
| Ampicillin | AMPICILLIN SODIUM | Sandoz Inc | f77db491-31c4-4a7c-a114-0f3244c97090 | 2024-05-07 | Warnings, Adverse reactions | JFN36L5S8K |
| AMPICILLIN | AMPICILLIN | HF Acquisition Co LLC, DBA HealthFirst | e47a21b1-bbdb-4321-e053-2a95a90a3b4a | 2024-01-28 | Warnings, Adverse reactions | JFN36L5S8K |
| AMPICILLIN | AMPICILLIN | HF Acquisition Co LLC, DBA HealthFirst | e51db6a3-027a-6e24-e053-2a95a90a1587 | 2024-01-14 | Warnings, Adverse reactions | JFN36L5S8K |
| Ampicillin | AMPICILLIN SODIUM | Medical Purchasing Solutions, LLC | 690f1986-6da9-4787-e053-2a91aa0a2644 | 2023-05-23 | Warnings, Adverse reactions | JFN36L5S8K |
| Ampicillin | AMPICILLIN SODIUM | Medical Purchasing Solutions, LLC | 70c022b0-ac9a-409b-e053-2a91aa0a757e | 2023-05-22 | Warnings, Adverse reactions | JFN36L5S8K |
| Ampicillin | AMPICILLIN | Medical Purchasing Solutions, LLC | bbf118c0-7cd3-5a82-e053-2a95a90ac8c8 | 2023-05-08 | Warnings, Adverse reactions | JFN36L5S8K |
| Ampicillin | AMPICILLIN | Medical Purchasing Solutions, LLC | c4310ee5-cbd3-99b5-e053-2995a90ae229 | 2023-04-27 | Warnings, Adverse reactions | JFN36L5S8K |
| Ampicillin | AMPICILLIN SODIUM | Fresenius Kabi USA, LLC | 8dbb4c71-8543-08f1-e053-2995a90af88d | 2022-10-21 | Warnings, Adverse reactions | JFN36L5S8K |
| adc826d7-09e9-44b1-ae5b-9d096395e053 | c7c4f344-7805-4961-bda5-3b2aacdd3383 | 2020-10-29 | Warnings, Adverse reactions | c7c4f344-7805-4961-bda5-3b2aacdd3383 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.